These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15717705)

  • 21. [Neuromuscular and cardiovascular effect of mivacurium in anesthesia induction in patients with renal failure].
    Blobner M; Jelen-Esselborn S; Mann R; Kling M; Schneider G; Schneck HJ; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):15-21. PubMed ID: 8868527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic-pharmacodynamic modeling of mivacurium in rats.
    Trocóniz IF; Garrido MJ; García E; Suárez E; Calvo R
    J Pharm Sci; 1997 Feb; 86(2):252-6. PubMed ID: 9040105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients.
    ØStergaard D; Viby-Mogensen J; Pedersen NA; Holm H; Skovgaard LT
    Acta Anaesthesiol Scand; 2002 Jul; 46(6):684-91. PubMed ID: 12059892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid method for the quantitation of mivacurium isomers in human and dog plasma by using liquid chromatography with fluorescence detection: application to pharmacokinetic studies.
    Lugo SI; Eddington ND
    J Pharm Biomed Anal; 1996 Apr; 14(6):675-83. PubMed ID: 8807542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs.
    Smith LJ; Schwark WS; Cook DR; Moon PF; Looney AL
    Am J Vet Res; 1999 Sep; 60(9):1051-4. PubMed ID: 10490070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure.
    Cook DR; Freeman JA; Lai AA; Kang Y; Stiller RL; Aggarwal S; Harrelson JC; Welch RM; Samara B
    Br J Anaesth; 1992 Dec; 69(6):580-5. PubMed ID: 1334687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of halothane on mivacurium infusion requirements in adult surgical patients.
    Kansanaho M; Olkkola KT
    Acta Anaesthesiol Scand; 1997 Jun; 41(6):754-9. PubMed ID: 9241338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic-pharmacodynamic modeling of doxacurium: effect of input rate.
    Zhu Y; Audibert G; Donati F; Varin F
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):23-37. PubMed ID: 9353692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium.
    Szenohradszky J; Fogarty D; Kirkegaard-Nielsen H; Brown R; Sharma ML; Fisher DM
    Anesthesiology; 2000 Mar; 92(3):708-14. PubMed ID: 10719950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postpartum patients have slightly prolonged neuromuscular block after mivacurium.
    Gin T; Derrick JL; Chan MT; Chui PT; Mak TW
    Anesth Analg; 1998 Jan; 86(1):82-5. PubMed ID: 9428856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical pharmacology of mivacurium].
    Diefenbach C; Mellinghoff H
    Anaesthesist; 1997 May; 46(5):385-8. PubMed ID: 9245207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between mivacurium and atracurium.
    Naguib M; Abdulatif M; al-Ghamdi A; Selim M; Seraj M; el-Sanbary M; Magboul MA
    Br J Anaesth; 1994 Oct; 73(4):484-9. PubMed ID: 7999489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia.
    Caldwell JE; Heier T; Kitts JB; Lynam DP; Fahey MR; Miller RD
    Br J Anaesth; 1989 Oct; 63(4):393-9. PubMed ID: 2530998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the duration of isoflurane anaesthesia on neuromuscular effects of mivacurium.
    Jalkanen L; Meretoja OA
    Acta Anaesthesiol Scand; 1997 Feb; 41(2):248-51. PubMed ID: 9062608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacodynamics and safety of mivacurium in infants and children under halothane-nitrous oxide anesthesia].
    Plaud B; Goujard E; Orliaguet G; Meistelman C; Ecoffey C
    Ann Fr Anesth Reanim; 1999 Dec; 18(10):1047-53. PubMed ID: 10652937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metoclopramide on mivacurium-induced neuromuscular block.
    Motamed C; Kirov K; Combes X; Dhonneur G; Duvaldestin P
    Acta Anaesthesiol Scand; 2002 Feb; 46(2):214-6. PubMed ID: 11942874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.
    Smith CE; van Miert MM; Parker CJ; Hunter JM
    Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B1090U) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane anaesthesia.
    From RP; Pearson KS; Choi WW; Abou-Donia M; Sokoll MD
    Br J Anaesth; 1990 Feb; 64(2):193-8. PubMed ID: 2138490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.